Rallybio
Price & Volume
Stats
See more52W Range | $2.40-$17.57 |
Market Cap | $92.2M |
Shares Short | 586,906 |
Financials
See moreRevenue (12 Mos) | $858,000 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$17.5M |
Diluted EPS | -$1.36 |
News
See moreYahoo Finance • 10 days ago
Quant rating check: Top oncology peers as Nuvalent goes private in $10.6B deal with GSK
Yahoo Finance • 18 days ago
Top Biotech Gainers: TTRX Turns Heads, LIXT Shifts To AI Energy, CNXU Update, QTRX, TRAX On Watch
Yahoo Finance • 3 months ago
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Rallybio Corporation (Nasdaq – RLYB), SunOpta Inc. (Nasdaq – STKL), Talkspace, Inc. (Nasdaq - TALK), Kennedy-Wilson Holdings, Inc. (Nasdaq - KW)
Yahoo Finance • 3 months ago
$HAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger—ALIS, TALK, JTAI, and RLYB
About
CEO | Dr. Stephen Uden M.D., MBBS |
CFO | Mr. Jonathan I. Lieber M.B.A. |
Address | 234 Church Street, New Haven, CT, United States, 06510 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 14 |